Douglas Bradley
Family Medicine · Belton, MONPI 1689669301
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.7% of the total across 195 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 10.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,309 and has fallen 97.7% since, to $30 in 2022.
Across 195 payments — averaging $13.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim$285
- AbbVie$251
- Novo Nordisk$249
- Pfizer$239
- Lilly USA, LLC$231
- AstraZeneca$200
- plus $1K from 22 others
What the payments were for
- Food & beverage$2,663100%
- Education$80%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boehringer Ingelheim | 19 | $285 |
| AbbVie(2 entities) | 18 | $251 |
| Novo Nordisk | 19 | $249 |
| Pfizer | 22 | $239 |
| Lilly USA, LLC | 19 | $231 |
| AstraZeneca | 13 | $200 |
| Biohaven Pharmaceuticals, Inc. | 7 | $119 |
| Johnson & Johnson | 10 | $119 |
| GSK | 8 | $109 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $87 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $83 |
| Novartis | 6 | $81 |
| Astellas Pharma US Inc | 5 | $81 |
| Otsuka America Pharmaceutical, Inc. | 5 | $69 |
| Merck | 5 | $67 |
| Sanofi-aventis U.S. LLC | 4 | $58 |
| Amgen | 4 | $51 |
| Esperion Therapeutics, Inc. | 3 | $42 |
| Angiodynamics, Inc. | 1 | $38 |
| Eisai Inc. | 3 | $37 |
| Dexcom, Inc. | 2 | $31 |
| Teva Pharmaceuticals USA, Inc. | 2 | $29 |
| Mylan Specialty L.p. | 2 | $26 |
| Adlon Therapeutics L.p. | 2 | $23 |
| Upsher-smith Laboratories LLC | 1 | $19 |
| Shire North American Group Inc | 1 | $18 |
| Almatica Pharma LLC | 1 | $15 |
| Boston Scientific | 1 | $13 |
How this compares
$2,671 in reported general payments places this provider in the 80th percentile of 2,203 family medicine providers in Missouri.
Other family medicine in Belton
- Kirk RidleyBelton$18K
- Stephen AdamsSpringfield$636K
- Justin PuckettKirksville$568K
- Matthew BeckerditeOfallon$225K
- Roger CadySpringfield$175K
- James LasalleExcelsior Springs$130K
- Matthew TiefenbrunnSullivan$105K
- Ayobami OduwoleGrandview$92K
- Michael DonovanSaint Louis$78K
- Blair ThedingerKansas City$71K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.